Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-12 08:27 am Purchase | 2024-07-15 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 3,257,891 20.940% | 420,000 (+14.80%) | Filing History |
| 2023-04-18 4:00 pm Purchase | 2023-04-14 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,837,891 19.750% | 2,837,891 (New Position) | Filing History |
| 2022-06-21 4:26 pm Purchase | 2022-06-13 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,761,349 18.950% | 2,761,349 (New Position) | Filing History |
| 2021-11-23 5:15 pm Purchase | 2021-11-18 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,598,199 17.470% | 438,000 (+20.28%) | Filing History |
| 2021-02-03 4:01 pm Purchase | 2021-02-01 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,160,199 16.260% | 384,747 (+21.67%) | Filing History |
| 2020-07-29 5:16 pm Purchase | 2020-07-24 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 1,775,452 13.780% | 520,900 (+41.52%) | Filing History |
| 2020-03-24 4:01 pm Purchase | 2020-03-18 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 1,254,553 12.070% | 323,957 (+34.81%) | Filing History |